The role of the plasmalemmal dopamine and vesicular monoamine transporters in methamphetamine-induced dopaminergic deficits.
Amphetamine (AMPH) and methamphetamine (METH) are members of a collection of phenethylamine psychostimulants that are commonly referred to collectively as "amphetamines." Amphetamines exert their effects, in part, by affecting neuronal dopamine transport. This review thus focuses on the effects of AMPH and METH on the plasmalemmal dopamine transporter and the vesicular monoamine transporter-2 in animal models with a particular emphasis on how these effects, which may vary for the different stereoisomers, contribute to persistent dopaminergic deficits.
Volz
Trent J
TJ
Department of Pharmacology and Toxicology, University of Utah, Salt Lake City, UT 84112, USA.
Hanson
Glen R
GR
Fleckenstein
Annette E
AE
D000818:Animals; D004298:Dopamine / Q000172:deficiency*; D050483:Dopamine Plasma Membrane Transport Proteins / Q000502:physiology*; D018765:Dopamine Uptake Inhibitors / Q000494:pharmacology*; D006801:Humans; D008694:Methamphetamine / Q000737:chemistry / Q000494:pharmacology*; D050493:Vesicular Monoamine Transport Proteins / Q000502:physiology*
D050483:Dopamine Plasma Membrane Transport Proteins; D018765:Dopamine Uptake Inhibitors; D050493:Vesicular Monoamine Transport Proteins; D008694:Methamphetamine; D004298:Dopamine